Monte Financial Statements From 2010 to 2024

GLUE Stock  USD 6.93  0.42  6.45%   
Monte Rosa financial statements provide useful quarterly and yearly information to potential Monte Rosa Therapeutics investors about the company's current and past financial position, as well as its overall management performance and changes in financial position over time. Historical trend examination of various income statement and balance sheet accounts found on Monte Rosa financial statements helps investors assess Monte Rosa's valuation, profitability, and current liquidity needs. Key fundamental drivers impacting Monte Rosa's valuation are summarized below:
Market Capitalization
425.8 M
Enterprise Value Revenue
15.0945
Revenue
15 M
Earnings Share
(1.78)
Revenue Per Share
0.221
There are over one hundred nineteen available fundamental ratios for Monte Rosa, which can be analyzed over time and compared to other ratios. Investors should ensure to check all of Monte Rosa's last-minute performance against the performance from 2010 to 2024 to make sure the company is sustainable down the road. As of December 23, 2024, Market Cap is expected to decline to about 275.9 M. In addition to that, Enterprise Value is expected to decline to about 197.9 M
Check Monte Rosa financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Monte Rosa's main balance sheet or income statement drivers, such as Net Interest Income of 9.4 M, Depreciation And Amortization of 3.9 M or Interest Expense of 4.5 M, as well as many indicators such as Price To Sales Ratio of 0.0, Dividend Yield of 0.0 or PTB Ratio of 1.7. Monte financial statements analysis is a perfect complement when working with Monte Rosa Valuation or Volatility modules.
  
Check out the analysis of Monte Rosa Correlation against competitors.

Monte Rosa Balance Sheet

Current ValueLast YearHistorical Average 10 Year Trend
Total Assets236 M303.8 M93.9 M
Slightly volatile
Short and Long Term Debt Total44.4 M46 M17.3 M
Slightly volatile
Other Current Liabilities12.2 M11.4 M4.7 M
Slightly volatile
Total Current Liabilities26.9 M46.6 M12.5 M
Slightly volatile
Property Plant And Equipment Net31.4 M62.6 M12.4 M
Slightly volatile
Accounts Payable7.9 M11.2 M4.8 M
Slightly volatile
Cash126.9 M128.1 M50.5 M
Slightly volatile
Non Current Assets Total34.9 M67.5 M13.7 M
Slightly volatile
Cash And Short Term Investments195.6 M232.4 M75.9 M
Slightly volatile
Net Receivables479.8 K505 K1.1 M
Slightly volatile
Common Stock Total Equity4.3 K4.5 K34.7 K
Slightly volatile
Common Stock Shares Outstanding51.3 M51.4 M45.4 M
Slightly volatile
Liabilities And Stockholders Equity236 M303.8 M93.9 M
Slightly volatile
Non Current Liabilities Total46.9 M77.9 M28.7 M
Slightly volatile
Other Current Assets3.6 M3.3 M1.6 M
Slightly volatile
Other Stockholder Equity335.2 M547.9 M123.9 M
Slightly volatile
Total Liabilities73.8 M124.5 M41.2 M
Slightly volatile
Property Plant And Equipment Gross78.6 M74.9 M16.6 M
Slightly volatile
Short and Long Term Debt600 K675 K735 K
Slightly volatile
Total Current Assets201.1 M236.2 M80.2 M
Slightly volatile
Capital Stock4.3 K4.5 K34.7 K
Slightly volatile
Net Working Capital174.2 M189.6 M67.7 M
Slightly volatile
Short Term Debt4.9 M6.3 M2.5 M
Slightly volatile
Common Stock4.3 K4.5 K34.7 K
Slightly volatile
Property Plant Equipment32.7 M31.1 M8.1 M
Slightly volatile
Other Liabilities1.8 M1.8 M1.3 M
Slightly volatile
Non Currrent Assets Other3.2 M4.9 M1.8 M
Slightly volatile
Other Assets4.1 M5.3 M2.1 M
Slightly volatile
Capital Surpluse536.4 M579.3 M485.2 M
Slightly volatile
Non Current Liabilities Other26.2 M52.2 M10 M
Slightly volatile
Inventory768 K864 K940.8 K
Slightly volatile
Current Deferred Revenue14.1 M15.9 M17.3 M
Slightly volatile

Monte Rosa Income Statement

Current ValueLast YearHistorical Average 10 Year Trend
Depreciation And Amortization3.9 M6.2 M1.7 M
Slightly volatile
Interest Expense4.5 M4.3 M915.5 K
Slightly volatile
Selling General Administrative17.5 M32 M6.9 M
Slightly volatile
Other Operating Expenses80.2 M143.3 M34.4 M
Slightly volatile
Research Development62.7 M111.3 M27.6 M
Slightly volatile
Cost Of Revenue3.9 M6.2 M1.5 M
Slightly volatile
Total Operating Expenses80.2 M143.3 M34.4 M
Slightly volatile
Reconciled Depreciation5.7 M5.4 M1.2 M
Slightly volatile
Interest Income9.4 MM1.5 M
Slightly volatile
Selling And Marketing Expenses7.6 M8.5 M9.3 M
Slightly volatile

Monte Rosa Cash Flow Statement

Current ValueLast YearHistorical Average 10 Year Trend
Net Borrowings7.2 M8.1 M8.8 M
Slightly volatile
Begin Period Cash Flow102.4 M60.2 M38.9 M
Slightly volatile
Other Cashflows From Financing Activities36.6 M27.5 M18.2 M
Slightly volatile
Depreciation6.5 M6.2 M1.3 M
Slightly volatile
Capital Expenditures10.2 M19 M4.6 M
Slightly volatile
Total Cash From Financing Activities26.1 M27.5 M44.1 M
Slightly volatile
End Period Cash Flow131.2 M132.7 M54.1 M
Slightly volatile
Change To Liabilities245.4 K258.3 K23.6 M
Slightly volatile
Cash Flows Other Operating800 K571.5 K1.2 M
Slightly volatile

Financial Ratios

Current ValueLast YearHistorical Average 10 Year Trend
Capex To Depreciation2.913.060314.177
Slightly volatile
Inventory Turnover7.148.028.7375
Slightly volatile
Days Of Inventory On Hand32.7536.8540.1208
Slightly volatile
Payables Turnover0.330.55790.1735
Slightly volatile
Cash Per Share2.984.52191.5209
Slightly volatile
Days Payables Outstanding62265411.3 K
Slightly volatile
Income Quality0.310.32360.7271
Slightly volatile
Current Ratio6.55.06984.5028
Slightly volatile
Graham Number8.4814.37534.7369
Slightly volatile
Capex Per Share0.390.37050.109
Slightly volatile
Interest Debt Per Share0.05840.06150.1415
Pretty Stable
Debt To Assets0.00990.01040.1391
Pretty Stable
Days Of Payables Outstanding62265411.3 K
Slightly volatile
Ebt Per Ebit1.130.94211.001
Slightly volatile
Long Term Debt To Capitalization2.853.23.4885
Slightly volatile
Quick Ratio6.495.06984.4997
Slightly volatile
Net Income Per E B T1.11.00251.0268
Pretty Stable
Cash Ratio4.562.74943.0433
Slightly volatile
Days Of Inventory Outstanding32.7536.8540.1208
Slightly volatile
Free Cash Flow Operating Cash Flow Ratio0.981.43471.2073
Pretty Stable
Debt Ratio0.00990.01040.1391
Pretty Stable

Monte Rosa Valuation Data

Current ValueLast YearHistorical Average 10 Year Trend
Market Cap275.9 M290.4 M808.5 M
Slightly volatile
Enterprise Value197.9 M208.3 M772.5 M
Slightly volatile

Monte Fundamental Market Drivers

Cash And Short Term Investments232.4 M

Monte Upcoming Events

21st of March 2024
Upcoming Quarterly Report
View
9th of May 2024
Next Financial Report
View
31st of December 2023
Next Fiscal Quarter End
View
21st of March 2024
Next Fiscal Year End
View
30th of September 2023
Last Quarter Report
View
31st of December 2022
Last Financial Announcement
View

About Monte Rosa Financial Statements

Monte Rosa stakeholders use historical fundamental indicators, such as Monte Rosa's revenue or net income, to determine how well the company is positioned to perform in the future. Although Monte Rosa investors may analyze each financial statement separately, they are all interrelated. For example, changes in Monte Rosa's assets and liabilities are reflected in the revenues and expenses on Monte Rosa's income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in Monte Rosa Therapeutics. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Current Deferred Revenue15.9 M14.1 M
Cost Of Revenue6.2 M3.9 M

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.
When determining whether Monte Rosa Therapeutics is a strong investment it is important to analyze Monte Rosa's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Monte Rosa's future performance. For an informed investment choice regarding Monte Stock, refer to the following important reports:
Check out the analysis of Monte Rosa Correlation against competitors.
You can also try the Bonds Directory module to find actively traded corporate debentures issued by US companies.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Monte Rosa. If investors know Monte will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Monte Rosa listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(1.78)
Revenue Per Share
0.221
Return On Assets
(0.28)
Return On Equity
(0.61)
The market value of Monte Rosa Therapeutics is measured differently than its book value, which is the value of Monte that is recorded on the company's balance sheet. Investors also form their own opinion of Monte Rosa's value that differs from its market value or its book value, called intrinsic value, which is Monte Rosa's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Monte Rosa's market value can be influenced by many factors that don't directly affect Monte Rosa's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Monte Rosa's value and its price as these two are different measures arrived at by different means. Investors typically determine if Monte Rosa is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Monte Rosa's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.